{"result": "(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición is a professional organization focused on endocrinology and nutrition in Spain, providing guidelines and consensus reports for clinical practices.)\n##\n(\"entity\"<|>ÁLVAREZ C<|>PERSON<|>Álvarez C is an author contributing to the consensus report on nutritional support and parenteral nutrition in oncology patients.)\n##\n(\"entity\"<|>MARTÍNEZ OLMOS MA<|>PERSON<|>Martínez Olmos MA is an author of the manual on nutritional assessment published by the Sociedad Española de Endocrinología y Nutrición.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>EVENT<|>Nutritional support provided at home for patients requiring parenteral nutrition, particularly in oncology cases.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition refers to the delivery of nutrients directly into the gastrointestinal tract, often used in patients unable to eat by mouth.)\n##\n(\"entity\"<|>NUTRICIÓN ORAL<|>EVENT<|>Oral nutrition involves providing nutrients through food and drink, which is the preferred method when possible for patients.)\n##\n(\"relationship\"<|>ÁLVAREZ C<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Álvarez C is a contributor to the guidelines published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>MARTÍNEZ OLMOS MA<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Martínez Olmos MA authored a manual published by the Sociedad Española de Endocrinología y Nutrición<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>NUTRICIÓN ENTERAL<|>Nutritional support methods including parenteral and enteral nutrition are discussed in the context of patient care<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>NUTRICIÓN ORAL<|>Nutritional support methods including parenteral and oral nutrition are discussed in the context of patient care<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NUTRICIÓN ORAL<|>Both enteral and oral nutrition are methods of providing nutritional support to patients, with specific indications for use<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ásico.\n         •  Evaluar la DMO al incluir a un paciente en un programa de nutrición parenteral domicilia-                                                 •  Se clasifica a los pacientes en tres categorías: bien nutridos (A), moderadamente desnu-\n            ria (NPD) si el pronóstico vital del enfermo lo justifica.                                                                                   tridos (B) y gravemente desnutridos (C). Se obtiene una puntuación que va a determinar\n         •  Realizar un diagnóstico diferencial entre osteopenia/osteoporosis y osteomalacia en pa-                                                      la necesidad o no de tratamiento.\n            cientes con baja DMO, especialmente a la hora de plantear una terapia.                                                                    •  Está diseñada específicamente para el paciente oncológico (hospitalizado o ambulato-\n         •  Sugerimos realizar una evaluación periódica (cada 1-2 años) de la DMO en los pacientes con                                                   rio). El tiempo de realización para ser cumplimentada en parte por el paciente es bajo.\n            NPD si el pronóstico del paciente lo justifica.\n         •  Evaluar las concentraciones de 25-OH-vitamina D en pacientes que sean incluidos en un                                                     Referencias:\n                                                                                                                                                      • Álvarez C, Ocón-Bretón MJ, Luengo Pérez LM, Viruzuela JA, Sendrós Maroño MJ, Cervera Peris M, et al. Soporte nutricional y nutrición\n            programa de NPD.                                                                                                                            parenteral en el paciente oncológico: informe de consenso de un grupo de expertos. Nutr Hosp. 2018;35(1):224-33.\n         •  Sugerimos plantear un tratamiento farmacológico en aquellos pacientes con NPD y afec-                                                     • Martínez Olmos MA, Villar Taibo R. Valoración del estado nutricional. Manual de Endocrinología y Nutrición. Sociedad Española de\n            tación ósea si el pronóstico vital lo justifica.                                                                                            Endocrinología y Nutrición. 2016. Disponible en: https://manual.seen.es.\n         •  Garantizar un adecuado aporte de vitamina D por vía oral o parenteral dada la elevada\n            prevalencia de deficiencia de vitamina D y la habitual coexistencia de malabsorción en\n            estos pacientes (RDA 600-800 UI/día).\n         •  En pacientes con NPD y osteoporosis sugerimos considerar los bifosfonatos intraveno-\n            sos o denosumab como una opción terapéutica.\n         •  En pacientes con larga expectativa de vida, sugerimos tratar con anabólicos en caso de\n            fracturas por fragilidad o mala respuesta al tratamiento con anticatabólicos.\n         Referencias:\n         • Reyes García R, Jódar Gimeno E, García Martín A, Romero Muñoz M, Gómez Sáez JM, Luque Fernández I, et al; Grupo de Metabolismo\n           Mineral de la Sociedad Española de Endocrinología y Nutrición. Guías de práctica clínica para la evaluación y tratamiento de la\n           osteoporosis asociada a enfermedades endocrinas y nutricionales. Endocrinol Nutr. 2012;59(3):174-96.\n\n\n\n246                                                                                                                                                                                                                                                                              247\n---\n                                                                                                                                                                                                                                                 NUTRICIÓN                             4\n\n\n\n     55  En el tratamiento se deja prescrita dieta líquida, analgesia y sueroterapia con 1.500                                                            COMENTARIO\n         ml de suero glucosalino. Tras la valoración nutricional, ¿qué intervención nutricional                                                           Los pacientes sometidos a cirugía pancreática pueden iniciar tolerancia temprana a nutri-\n         terapéutica inicial le parece la más adecuada?                                                                                                   ción oral, habiendo demostrado que es segura. La nutrición enteral y parenteral quedaría\n         A. Indicar nutrición enteral completa por vía oral hasta la cirugía y revisar evolución pasadas                                                  reservada para pacientes con complicaciones posquirúrgicas.\n              48 horas.                                                                                                                                   En la cirugía mayor gastrointestinal se ha demostrado que la nutrición enteral precoz frente\n         B. Indicar nutrición enteral completa a través de sonda nasogástrica, ya que es poco                                                             a la nutrición parenteral disminuye las complicaciones infecciosas posoperatorias, la es-\n              probable que cumpla requerimientos por vía oral y revisar evolución pasadas 48 horas.                                                       tancia hospitalaria y el gasto sanitario.\n         C. Indicar dieta líquida, ya que tiene las mismas kilocalorías que la dieta basal del hospital                                                   En el soporte nutricional postoperatorio:\n              y revisar evolución pasadas 48 horas.                                                                                                       •  Si la vía oral es posible, se valorará si el paciente cubre sus requerimientos calórico-pro-\n         D.   No es necesaria ninguna medida especial; el plazo de 7 días en este paciente nos permite                                                       teicos con los aportes dietéticos, y se añadirán suplementos orales en caso de no llegar\n              mantener la sueroterapia.                                                                                                                      al\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}